BMC Cancer

official impact factor 3.15

Open Access Highly Access

Treatment of primary glioblastoma multiforme with cetuximab, radiotherapy and temozolomide (GERT) – phase I/II trial: study protocol

Stephanie E Combs*, Steffen Heeger, Renate Haselmann, Lutz Edler, Jürgen Debus and Daniela Schulz-Ertner

BMC Cancer 2006, 6:133 doi:10.1186/1471-2407-6-133

Accesses  

  • Last 30 days: 88 accesses
  • Last 365 days: 1246 accesses
  • All time: 9714 accesses

Cited by

BioMed Central: 1 citation